申请人:FUKUSHIMA Tae
公开号:US20120238750A1
公开(公告)日:2012-09-20
The compound of the present invention is represented by the following general formula (1):
[wherein X
1
represents a nitrogen atom or a group —CH═; R
1
represents a group —Z—R
6
, wherein Z represents a group —CO—, a group —CH(OH)—, or the like, and R
6
represents a 5- to 15-membered monocyclic, dicyclic, or tricyclic, saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms, or sulfur atoms; R
2
represents a hydrogen atom, a halogen atom or a lower alkylene group; Y represents a group —O—, a group —CO—, a group —CH(OH)—, a lower alkylene group, or the like; and A represents a group
or the like, wherein R
3
represents a hydrogen atom, a lower alkoxy group, or the like, p represents 1 or 2, and R
4
represents an imidazolyl lower alkyl group or the like.
本发明的化合物由以下通式(1)表示:[其中X1表示氮原子或基团—CH═; R1表示基团—Z—R6,其中Z表示基团—CO—、基团—CH(OH)—或类似物,而R6表示具有1至4个氮原子、氧原子或硫原子的5至15环的单环、双环或三环、饱和或不饱和的杂环基团; R2表示氢原子、卤素原子或较低的烷基链; Y表示基团—O—、基团—CO—、基团—CH(OH)—、较低的烷基链或类似物; A表示基团或类似物,其中R3表示氢原子、较低的烷氧基或类似物,p表示1或2,而R4表示咪唑基较低的烷基链或类似物。